Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer
NCT01708798
ABOUT THIS STUDY
FOR MORE INFORMATION
Contact a representative by phone, email, or visiting the study website. Please see the references below:
Pfizer Clinical Trials Contact Center
1-800-718-1021
- Stage I-III breast cancer
- Scheduled to undergo treatment with doxorubicin-based chemotherapy regimen
- Able to provide informed consent
- Use of anthracycline agents other than doxorubicin
- Baseline LVEF ≤50% by any modality (nuclear, echo, MRI)
- Atrial fibrillation or flutter
- Mitral valve disease (More than mild mitral stenosis or regurgitation, previous mitral
valve replacement or repair)
- Inability to obtain adequate echo images for required analysis
- Hyperkalemia (K+ >5.0)
- Glomerular filtration rate (GFR) <30 ml/min/1.73m2
- Uncontrolled hypertension, defined as having a systolic blood pressure > 180 mmHg
and/or a diastolic blood pressure >110 mmHg
- Symptomatic hypotension or systolic blood pressure <85 mmHg
- History of hypersensitivity to eplerenone or spironolactone
- Significant hepatic disease (e.g., previously documented positive serology for viral
hepatitis) or aspartate aminotransferase (AST) and/or alanine aminotransferase (ALT)
>3 times the upper limits of normal
- Concomitant treatment with spironolactone, potassium-sparing diuretics, potassium
supplements, or strong inhibitors of cytochrome P450 3A4 (CYP3A4) (i.e. ketoconazole,
itraconazole, nefazodone, troleandomycin, clarithromycin, ritonavir, nelfinavir)
- History of alcohol and/or any other drug abuse
- Women who are either pregnant, lactating or of childbearing potential and not using an
acceptable method of contraception
- Other severe acute or chronic medical or psychiatric condition or laboratory
abnormality that may increase the risk associated with trial participation or
investigational product administration or may interfere with the interpretation of
trial results and, in the judgment of the investigator, would make the subject
inappropriate for entry into this trial
NEED INFO?
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
- Kagoshima,
- Akita,
- Washington, District of Columbia
- Baltimore, Maryland